Discover a study where researchers have discovered a myeloid-derived antigen-presenting cells population essential for peripherally induced regulatory T cells.

Many different cancer treatments work to directly target the tumor or the cells around it. The immediate goal is to mitigate ...

T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...

IDO1 and PDL1 are immune checkpoints with key roles in immune system regulation. Their relevance stems from their ability to suppress T-cell function. T-cells are vital to the body’s immune response ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

Pfizer Inc. today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus ...

ImmunityBio, Inc. , a leading immunotherapy company, will announce new clinical findings for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in non-muscle invasive bladder cancer carcinoma in situ (NMIBC ...

Apr. 18, 2025 — When the immune system does not function properly ... Called 'tolerogenic dendritic cells,' these ... New Immune Boost Could Expand Access to Cancer Immunotherapy Apr. 11 ...

An NIH-funded project leverages advanced synapse imaging to monitor real-time neuronal changes during learning, unveiling new ...

Unprecedented dataset links neuronal activity to synaptic wiring at the millimeter scale, offering open-access tools for ...